Most linked-to pages

Jump to navigation Jump to search

Showing below up to 50 results in range #751 to #800.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Tovetumab (2 links)
  2. Tralokinumab (2 links)
  3. Transformation (2 links)
  4. Transplant rejection (2 links)
  5. Trastuzumab (2 links)
  6. Trastuzumab emtansine (2 links)
  7. Traumatic shock (2 links)
  8. Tregalizumab (2 links)
  9. Tremelimumab (2 links)
  10. Trevogrumab (2 links)
  11. Tucotuzumab celmoleukin (2 links)
  12. Tumor-associated glycoprotein 72 (2 links)
  13. Tumor antigen (2 links)
  14. Tumor endothelial marker 1 (2 links)
  15. Tumor necrosis factor receptor (2 links)
  16. Tuvirumab (2 links)
  17. Ublituximab (2 links)
  18. Ulcerative colitis (2 links)
  19. Ulocuplumab (2 links)
  20. Urelumab (2 links)
  21. Urtoxazumab (2 links)
  22. Ustekinumab (2 links)
  23. Utomilumab (2 links)
  24. Uveitis (2 links)
  25. VEGF-A (2 links)
  26. VEGFR-1 (2 links)
  27. VEGFR2 (2 links)
  28. Vadastuximab talirine (2 links)
  29. Vandortuzumab vedotin (2 links)
  30. Vantictumab (2 links)
  31. Vanucizumab (2 links)
  32. Vapaliximab (2 links)
  33. Varlilumab (2 links)
  34. Vascular endothelial growth factor A (2 links)
  35. Vatelizumab (2 links)
  36. Vedolizumab (2 links)
  37. Veltuzumab (2 links)
  38. Vepalimomab (2 links)
  39. Vesencumab (2 links)
  40. Vimentin (2 links)
  41. Virus-like particle Production (2 links)
  42. Visilizumab (2 links)
  43. Vobarilizumab (2 links)
  44. Volociximab (2 links)
  45. Vorsetuzumab mafodotin (2 links)
  46. Votumumab (2 links)
  47. X-linked hypophosphatemia (2 links)
  48. Xentuzumab (2 links)
  49. Zalutumumab (2 links)
  50. Zanolimumab (2 links)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://eln.excellgen.com/index.php?title=Special:MostLinkedPages"